Richard F Pops insider trades: Neurocrine Biosciences (NBIX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
89 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | NBIX | ↓ Sell | 15,000 | $157.65 | $2.4M | Direct | May 18, 2026 (3d) |
| May 17, 2024 | NBIX | ↓ Sell | 2,100 | $141.84 | $298K | Direct | May 21, 2024 (4d) |
| Mar 13, 2024 | NBIX | ↓ Sell | 23,200 | $140.33 | $3.3M | Direct | Mar 15, 2024 (2d) |
| Mar 11, 2024 | NBIX | ↓ Sell | 1,800 | $140.04 | $252K | Direct | Mar 12, 2024 (1d) |
| Feb 20, 2024 | NBIX | ↓ Sell | 15,000 | $132.47 | $2.0M | Direct | Feb 22, 2024 (2d) |
| Jan 3, 2023 | NBIX | ↓ Sell | 15,000 | $119.20 | $1.8M | Direct | Jan 5, 2023 (2d) |
| May 9, 2022 | NBIX | ↓ Sell | 15,000 | $76.30 | $1.1M | Direct | May 11, 2022 (2d) |
| May 6, 2022 | ALKS | ↓ Sell | 347,257 | $27.98 | $9.7M | Direct | May 6, 2022 (0d) |
| May 18, 2021 | ALKS | ↓ Sell | 150,000 | $21.90 | $3.3M | Direct | May 19, 2021 (1d) |
| May 11, 2021 | ALKS | ↓ Sell | 150,000 | $22.09 | $3.3M | Direct | May 12, 2021 (1d) |
| May 6, 2021 | ALKS | ↓ Sell | 100,000 | $21.79 | $2.2M | Direct | May 7, 2021 (1d) |
| May 14, 2020 | ALKS | ↓ Sell | 75,000 | $15.00 | $1.1M | Direct | May 14, 2020 (0d) |
| May 7, 2020 | ALKS | ↓ Sell | 50,000 | $14.63 | $731K | Direct | May 7, 2020 (0d) |
| Apr 2, 2020 | ALKS | ↓ Sell | 50,000 | $13.79 | $690K | Direct | Apr 3, 2020 (1d) |
| Mar 26, 2020 | ALKS | ↓ Sell | 75,000 | $14.36 | $1.1M | Direct | Mar 26, 2020 (0d) |
| Mar 19, 2020 | ALKS | ↓ Sell | 75,000 | $14.47 | $1.1M | Direct | Mar 19, 2020 (0d) |
| Nov 14, 2019 | ALKS | ↓ Sell | 100,000 | $19.50 | $1.9M | Direct | Nov 15, 2019 (1d) |
| Nov 8, 2019 | ALKS | ↓ Sell | 100,000 | $19.78 | $2.0M | Direct | Nov 8, 2019 (0d) |
| Sep 19, 2019 | ALKS | ↓ Sell | 100,000 | $21.54 | $2.2M | Direct | Sep 23, 2019 (4d) |
| Sep 12, 2019 | ALKS | ↓ Sell | 100,000 | $22.68 | $2.3M | Direct | Sep 13, 2019 (1d) |
| Sep 5, 2019 | ALKS | ↓ Sell | 100,000 | $20.18 | $2.0M | Direct | Sep 6, 2019 (1d) |
| May 23, 2019 | ALKS | ↓ Sell | 110,000 | $24.88 | $2.7M | Direct | May 24, 2019 (1d) |
| Mar 13, 2019 | ALKS | ↓ Sell | 60,000 | $33.32 | $2.0M | Direct | Mar 14, 2019 (1d) |
| Mar 5, 2019 | ALKS | ↓ Sell | 50,000 | $33.63 | $1.7M | Direct | Mar 7, 2019 (2d) |
| Nov 26, 2018 | NBIX | ↓ Sell | 4,124 | $91.37 | $377K | Direct | Nov 27, 2018 (1d) |
| Nov 12, 2018 | NBIX | ↓ Sell | 4,123 | $103.30 | $426K | Direct | Nov 13, 2018 (1d) |
| Oct 29, 2018 | NBIX | ↓ Sell | 5,500 | $107.13 | $589K | Direct | Oct 30, 2018 (1d) |
| May 22, 2018 | ALKS | ↓ Sell | 20,000 | $45.46 | $909K | Direct | May 24, 2018 (2d) |
| May 15, 2018 | ALKS | ↓ Sell | 50,000 | $46.38 | $2.3M | Direct | May 17, 2018 (2d) |
| May 8, 2018 | ALKS | ↓ Sell | 50,000 | $44.32 | $2.2M | Direct | May 10, 2018 (2d) |
| May 1, 2018 | ALKS | ↓ Sell | 50,000 | $44.02 | $2.2M | Direct | May 3, 2018 (2d) |
| Mar 6, 2018 | XLRN | ↓ Sell | 37,500 | $41.42 | $1.6M | Direct | Mar 8, 2018 (2d) |
| Nov 2, 2017 | ALKS | ↓ Sell | 50,000 | $48.87 | $2.4M | Direct | Nov 3, 2017 (1d) |
| May 24, 2017 | ALKS | ↓ Sell | 25,000 | $57.42 | $1.4M | Direct | May 25, 2017 (1d) |
| May 17, 2017 | ALKS | ↓ Sell | 50,000 | $58.19 | $2.9M | Direct | May 19, 2017 (2d) |
| May 10, 2017 | ALKS | ↓ Sell | 25,000 | $57.29 | $1.4M | Direct | May 11, 2017 (1d) |
| Nov 29, 2016 | ALKS | ↓ Sell | 30,000 | $56.98 | $1.7M | Direct | Nov 30, 2016 (1d) |
| Nov 22, 2016 | ALKS | ↓ Sell | 30,000 | $58.66 | $1.8M | Direct | Nov 22, 2016 (0d) |
| Nov 15, 2016 | ALKS | ↓ Sell | 30,000 | $58.82 | $1.8M | Direct | Nov 17, 2016 (2d) |
| Nov 8, 2016 | ALKS | ↓ Sell | 30,000 | $53.28 | $1.6M | Direct | Nov 10, 2016 (2d) |
| May 25, 2016 | NBIX | ↓ Sell | 15,000 | $46.72 | $701K | Direct | May 26, 2016 (1d) |
| Apr 19, 2016 | ALKS | ↓ Sell | 18,750 | $40.15 | $753K | Direct | Apr 20, 2016 (1d) |
| Apr 12, 2016 | ALKS | ↓ Sell | 25,000 | $37.79 | $945K | Direct | Apr 13, 2016 (1d) |
| Mar 22, 2016 | ALKS | ↓ Sell | 25,000 | $31.77 | $794K | Direct | Mar 23, 2016 (1d) |
| Mar 15, 2016 | ALKS | ↓ Sell | 25,000 | $31.40 | $785K | Direct | Mar 16, 2016 (1d) |
| Dec 7, 2015 | ALKS | ↓ Sell | 37,500 | $72.06 | $2.7M | Direct | Dec 8, 2015 (1d) |
| Dec 1, 2015 | ALKS | ↓ Sell | 50,000 | $72.29 | $3.6M | Direct | Dec 2, 2015 (1d) |
| Sep 17, 2015 | ALKS | ↓ Sell | 50,000 | $71.27 | $3.6M | Direct | Sep 17, 2015 (0d) |
| Sep 10, 2015 | ALKS | ↓ Sell | 50,000 | $67.57 | $3.4M | Direct | Sep 10, 2015 (0d) |
| Dec 11, 2014 | ALKS | ↓ Sell | 100,000 | $56.04 | $5.6M | Direct | Dec 11, 2014 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NBIX insiders
Open-market trades in the last 12 months
About Richard F Pops's insider trades
Richard F Pops is a director at Neurocrine Biosciences (NBIX). Since Nov 23, 2005, Richard has reported no open-market purchases and 89 sales worth $146.4M on SEC Form 4. In the last 12 months: 1 sale ($2.4M).
Their filings also include option exercises (129 filings), grants and awards (78 filings), shares withheld for taxes (63 filings), shares returned to the company (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NBIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.